Bahrain begins world’s first WHO-listed stage 3 clinical trial of COVID-19 vaccine

Bahrain has begun phase three of clinical trials for a COVID-19 vaccine, in cooperation with those in charge of the experience from the United Arab Emirates (UAE) and their Chinese partners, Supreme Council of Health (SCH) President and National Medical Task Force to Combat the Coronavirus (COVID-19) Chairman, Lieutenant-General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, has revealed.
 
SCH chief was speaking as he received here today a delegation of the officials of the potential vaccine, including those in charge of the experience in the UAE, Dr. Nawal Al-Kaabi and Dr. Waleed Abbas, in addition to representatives of Sinopharm’s China National Biotec Group (CNBG), and artificial intelligence and cloud computing company, Group 42.
 
Dr. Shaikh Mohammed bin Abdulla welcomed the delegation’s visit to the kingdom, stressing that exchanging expertise and visits regarding the pandemic will contribute to containing its spread.
 
He also affirmed Bahrain’s unwavering keenness to protect the safety and health of everyone through stepping up its efforts to combat the virus, praising the ongoing close cooperation with brotherly UAE.
 
He revealed that the kingdom will participate in the first global clinical trials for the third phase of WHO-listed potential coronavirus vaccine, noting that the vaccine will be tested on 6,000 volunteer citizens and residents in Bahrain.
 
SCH President highlighted the efforts made by the kingdom and the National Medical Task Force to Combat the Coronavirus to fight the pandemic and ensure the health and safety of the citizens and residents.
 
The delegation lauded the kingdom’s efforts and measures to contain the pandemic through its precautionary and pre-emptive measures that are consistent with international standards and the recommendations of the World Health Organisation.